博瑞医药
(688166)
| 流通市值：217.05亿 | | | 总市值：217.05亿 |
| 流通股本：4.23亿 | | | 总股本：4.23亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 739,834,101.15 | 812,681,675.88 | 765,353,408.15 | 505,357,865.57 |
| 交易性金融资产 | - | - | 0 | 0 |
| 应收票据及应收账款 | 266,222,283.98 | 279,710,403.85 | 329,177,703.49 | 369,536,455.4 |
| 其中：应收票据 | 561,863.51 | 2,934,536.96 | 1,401,186.87 | 0 |
| 应收账款 | 265,660,420.47 | 276,775,866.89 | 327,776,516.62 | 369,536,455.4 |
| 应收款项融资 | 10,582,211.46 | 5,523,820.19 | 10,326,279.64 | 2,253,603.74 |
| 预付款项 | 89,901,721.58 | 49,610,071.01 | 104,833,585.27 | 107,954,668.17 |
| 其他应收款合计 | 7,673,356.77 | 2,025,851.04 | 6,662,961.27 | 3,032,209.5 |
| 其中:应收利息 | - | - | 0 | 0 |
| 应收股利 | - | - | 0 | 0 |
| 存货 | 372,419,753.39 | 365,680,037.04 | 364,614,796.55 | 339,742,470.71 |
| 其他流动资产 | 57,294,239.64 | 56,364,726.7 | 59,309,031.77 | 54,640,056.19 |
| 流动资产合计 | 1,543,927,667.97 | 1,571,596,585.71 | 1,640,277,766.14 | 1,382,517,329.28 |
| 非流动资产: | | | | |
| 长期应收款 | 4,100,000 | 4,100,000 | 2,100,000 | - |
| 长期股权投资 | 138,570,966.89 | 37,969,215.94 | 39,043,408.27 | 39,325,778.89 |
| 其他权益工具投资 | 73,763,126.42 | 86,144,167.78 | 86,195,932.73 | 85,453,039.67 |
| 其他非流动金融资产 | 76,207,977.95 | 75,519,569.93 | 73,791,197.79 | 58,945,678.24 |
| 投资性房地产 | 58,125,089.89 | 58,845,712.57 | 59,566,335.25 | 60,286,957.93 |
| 固定资产 | 1,463,076,322.57 | 1,491,235,661.86 | 1,516,653,376.2 | 1,075,681,761.85 |
| 在建工程 | 1,235,714,599.62 | 1,201,042,721.66 | 1,167,043,420.42 | 1,621,450,042.69 |
| 使用权资产 | 17,251,757.58 | 20,859,929.19 | 21,548,596.91 | 23,513,017.43 |
| 无形资产 | 86,792,258.77 | 88,288,104.11 | 89,481,499.03 | 90,827,095.4 |
| 开发支出 | 224,490,016.39 | 183,674,072.4 | 14,337,087.12 | 9,258,962.26 |
| 商誉 | 3,120,100 | 3,120,100 | 3,120,100 | 7,500,000 |
| 长期待摊费用 | 39,872,684.96 | 42,545,333.66 | 43,149,414.93 | 28,604,665.65 |
| 递延所得税资产 | 70,466,777.4 | 82,358,685.61 | 65,719,298.87 | 56,071,439.09 |
| 其他非流动资产 | 348,315,232.11 | 337,973,436.39 | 334,491,009.23 | 339,097,043.42 |
| 非流动资产合计 | 3,839,866,910.55 | 3,713,676,711.1 | 3,516,240,676.75 | 3,496,015,482.52 |
| 资产总计 | 5,383,794,578.52 | 5,285,273,296.81 | 5,156,518,442.89 | 4,878,532,811.8 |
| 流动负债: | | | | |
| 短期借款 | 168,732,665.76 | 131,419,652.77 | 115,263,719.28 | 122,138,205.34 |
| 交易性金融负债 | 121,142.81 | 1,678,957.59 | 3,734,726.18 | 382,600 |
| 应付票据及应付账款 | 202,694,593.27 | 209,466,569.37 | 266,002,365.63 | 213,842,003.41 |
| 其中：应付票据 | 50,000,000 | 25,000,000 | 55,000,000 | 39,775,702.02 |
| 应付账款 | 152,694,593.27 | 184,466,569.37 | 211,002,365.63 | 174,066,301.39 |
| 合同负债 | 28,821,616.16 | 34,884,385.09 | 28,019,474.35 | 28,549,329.77 |
| 应付职工薪酬 | 18,236,636 | 43,140,065.45 | 51,809,244.02 | 14,637,196.78 |
| 应交税费 | 5,783,760.55 | 8,575,171.41 | 26,651,413.42 | 15,972,449.15 |
| 其他应付款合计 | 52,899,975.24 | 9,914,134.51 | 8,494,487.28 | 9,341,695.56 |
| 其中:应付利息 | - | - | 0 | 0 |
| 应付股利 | - | - | 0 | 0 |
| 一年内到期的非流动负债 | 661,156,902.04 | 480,935,520.71 | 537,366,789.87 | 463,613,234.3 |
| 其他流动负债 | 18,555,160.62 | 18,179,806.69 | 15,043,137.49 | 17,007,915.47 |
| 流动负债合计 | 1,157,002,452.45 | 938,194,263.59 | 1,052,385,357.52 | 885,484,629.78 |
| 非流动负债: | | | | |
| 长期借款 | 1,039,837,474.2 | 1,155,361,436.71 | 1,109,933,478.66 | 1,104,249,061.43 |
| 应付债券 | 454,709,579.64 | 457,913,213.27 | 455,344,423.73 | 448,356,214.47 |
| 租赁负债 | 7,920,825.56 | 8,444,328.28 | 10,207,436.03 | 20,053,243.33 |
| 长期应付款 | 67,000,051.63 | 36,231,046 | 24,389,248.41 | 69,550,000 |
| 递延收益 | 71,157,259.96 | 73,112,154.99 | 74,710,350 | 8,500,000 |
| 递延所得税负债 | - | - | 3,518,157.56 | - |
| 非流动负债合计 | 1,640,625,190.99 | 1,731,062,179.25 | 1,678,103,094.39 | 1,650,708,519.23 |
| 负债合计 | 2,797,627,643.44 | 2,669,256,442.84 | 2,730,488,451.91 | 2,536,193,149.01 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 422,768,244 | 422,466,646 | 422,466,646 | 422,466,561 |
| 其他权益工具 | 62,840,182.63 | 75,639,147.66 | 64,293,275.51 | 75,639,635.72 |
| 永续债 | - | 75,639,147.66 | - | - |
| 资本公积 | 1,094,526,817.77 | 1,076,444,676.59 | 982,363,010.94 | 949,381,893.93 |
| 减:库存股 | 10,009,948.64 | 10,009,948.64 | 10,009,948.64 | 10,009,948.64 |
| 其他综合收益 | -124,695,066.81 | -122,185,574.81 | -122,115,353.67 | -119,642,893.27 |
| 盈余公积 | 86,060,862.59 | 85,464,856.69 | 85,464,856.69 | 67,219,535.13 |
| 未分配利润 | 942,825,589.68 | 973,798,977.73 | 960,839,201.64 | 967,326,338.8 |
| 归属于母公司股东权益合计 | 2,474,316,681.22 | 2,501,618,781.22 | 2,383,301,688.47 | 2,352,381,122.67 |
| 少数股东权益 | 111,850,253.86 | 114,398,072.75 | 42,728,302.51 | -10,041,459.88 |
| 股东权益合计 | 2,586,166,935.08 | 2,616,016,853.97 | 2,426,029,990.98 | 2,342,339,662.79 |
| 负债和股东权益合计 | 5,383,794,578.52 | 5,285,273,296.81 | 5,156,518,442.89 | 4,878,532,811.8 |
| 公告日期 | 2025-08-29 | 2025-04-18 | 2025-04-03 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |